NCT06965491

Brief Summary

The study aims to investigate the effects of post-exercise and pre-sleep ketosis via oral ketone ester supplementation on physical and mental recovery during a multi-day cycling stage race.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2024

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

October 4, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 27, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 11, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2025

Completed
Last Updated

February 20, 2026

Status Verified

May 1, 2025

Enrollment Period

1.1 years

First QC Date

October 4, 2024

Last Update Submit

February 19, 2026

Conditions

Keywords

ultra-endurancecyclingphysiological strainmental fatigue

Outcome Measures

Primary Outcomes (10)

  • Muscle soreness

    Visual analog scale (0-10) How sore does you leg muscles feel? The VAS was used as a subjective measure of muscle soreness

    During the intervention

  • Physical stress

    RESTQ-76 sport questionnaire was used to assess the stress-recovery balance

    pre-intervention and 1 day after the intervention

  • Hydration status

    Before every stage, the participants provided a urine sample in a cup. A urine-specific refractometer (Atago) was used to determine their hydration status

    Baseline, During the intervention and 1 day after the intervention

  • Cognitive function: reaction time

    CANTAB test battery reaction time test was used to determine reaction time in milliseconds.

    Pre-intervention, day 2, 4 and 8 of the intervention

  • Cognitive function: rapid visual processing

    CANTAB test battery rapid visual processing test was used to assess their susceptibility to false alarms

    Pre-intervention, day 2, 4 and 8 of the intervention

  • Cognitive function: swm

    CANTAB spatial working memory test was used to access executive function; the main outcome measure used was the number of errors

    Pre-intervention, day 2, 4 and 8 of the intervention

  • Sleep Duration

    Fitbit inspire 3 was used to measure sleep duration (hours:minutes:seconds)

    1 week prior to racing and during the race

  • Sleep: REM

    The Fitbit Inspire 3 was used to measure the total duration of rapid eye motion (REM)sleep during each night for the duration of the study. The REM sleep phase will be analysed in minutes

    1 week prior to racing and during the race

  • Sleep: Non-REM

    The Fitbit Inspire 3 will be used to determine the NON-REM sleep phase for each night in minutes

    1 week prior to racing and during the race

  • Sleep: WASO

    The FITBIT inspire 3 will be used to measure wake after sleep onset in minutes for each night

    1 week prior to racing and during the race

Secondary Outcomes (7)

  • Mechanical efficiency

    pre-intervention and 1 day after the intervention

  • Time trial performance

    pre-intervention and 1 day after the intervention

  • Appetite

    pre-intervention, during the intervention, 1 day after the intervention

  • Macronutrient intake

    baseline, during the intervention

  • Total energy intake

    baseline, during the intervention

  • +2 more secondary outcomes

Study Arms (2)

Control group

PLACEBO COMPARATOR

Intervention: 8-day multistage mountain bike race/simulation Dietary intervention: placebo supplement (oral supplement containing: 16.4 grams of medium chained triglycerides, 1mM of sucrose octaacetate and water)

Dietary Supplement: Placebo Supplement

Experimental group

EXPERIMENTAL

Intervention: 8-day multistage mountain bike race/simulation Dietary intervention: ketone ester supplement (25 grams of pure R-(3)-hydroxybutyl-(R)-3-hydroxybutyrate ketone monoester drink)

Dietary Supplement: Ketone ester supplement

Interventions

Placebo SupplementDIETARY_SUPPLEMENT

Placebo supplement: Oral supplement containing: 16.4 grams of medium chained triglycerides, 1mM or sucrose octaacetate and water

Control group
Ketone ester supplementDIETARY_SUPPLEMENT

Ketone ester supplement Oral supplement containing: 25 grams of pure (R)-3-hydroxybutyl-(R)-3-hydroxybutyrate ketone monoester drink

Experimental group

Eligibility Criteria

Age18 Years - 59 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • have been cycling consistently for at least 1 year before entry into the study
  • have been cycling for a minimum of 7 hours per week for the 6 months leading up to the study
  • additional for the field study: valid entry to the 2025 edition of the Absa Cape Epic
  • non-smoker

You may not qualify if:

  • Do not follow a ketogenic diet or low-carbohydrate diet
  • Have any metabolic or auto-immune disease that will influence their metabolism
  • Take medication or supplements that is known to affect ketone supplement metabolism
  • suffering from a recurring injury or illness from which they have not fully recovered that is a contr-indication to perform high-intensity exercise
  • Unable to finish each stage
  • Women: if they are pregnant or breastfeeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KU Leuven

Leuven, Vlaams-Brabant, 3000, Belgium

Location

MeSH Terms

Conditions

FatigueMental Fatigue

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehavior

Study Officials

  • Chiel PoffĂ©

    KU Leuven

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Participants and investigators are blinded from the experimental condition (KE or CON). Supplements are provided in non transparent tubes and the control supplement is identical in taste and viscosity to the ketone supplement.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Riders will be paired matched and randomly assigned to either the ketone ester supplementation (KE) group or the control group (CON) which will receive an isocaloric taste-matched placebo
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 4, 2024

First Posted

May 11, 2025

Study Start

March 1, 2024

Primary Completion

March 27, 2025

Study Completion

October 30, 2025

Last Updated

February 20, 2026

Record last verified: 2025-05

Locations